|
1
|
American Cancer Society, . Cancer Facts
and Figures 2019. Atlanta: American Cancer Society;2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2019/cancer-facts-and-figures-2019.pdfFebruary
20–2019
|
|
2
|
Van Cutsem E and Oliveira J: ESMO
Guidelines Working Group: Advanced colorectal cancer: ESMO clinical
recommendations for diagnosis, treatment and follow-up. Ann Oncol.
20 (Suppl 4):S61–S63. 2009. View Article : Google Scholar
|
|
3
|
Wang T, Niu G, Kortylewski M, Burdelya L,
Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola
D, et al: Regulation of the innate and adaptive immune responses by
Stat-3 signaling in tumor cells. Nat Med. 10:48–54. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beatty GL and Gladney WL: Immune escape
mechanisms as a guide for cancer immunotherapy. Clin Cancer Res.
21:687–692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Camus M, Tosolini M, Mlecnik B, Pagès F,
Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval
P, et al: Coordination of intratumoral immune reaction and human
colorectal cancer recurrence. Cancer Res. 69:2685–2693. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baier PK, Wimmenauer S, Hirsch T, von
Specht BU, von Kleist S, Keller H and Farthmann EH: Analysis of the
T cell receptor variability of tumor-infiltrating lymphocytes in
colorectal carcinomas. Tumour Biol. 19:205–212. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hsu FJ, Benike C, Fagnoni F, Liles TM,
Czerwinski D, Taidi B, Engleman EG and Levy R: Vaccination of
patients with B-cell lymphoma using autologous antigen-pulsed
dendritic cells. Nat Med. 2:52–58. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rains N, Cannan RJ, Chen W and Stubbs RS:
Development of a dendritic cell (DC)-based vaccine for patients
with advanced colorectal cancer. Hepatogastroenterology.
48:347–351. 2001.PubMed/NCBI
|
|
9
|
Trombetta ES and Mellman I: Cell biology
of antigen processing in vitro and in vivo. Annu Rev Immunol.
23:975–1028. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Datta J, Terhune JH, Lowenfeld L, Cintolo
JA, Xu S, Roses RE and Czerniecki BJ: Optimizing dendritic
cell-based approaches for cancer immunotherapy. Yale J Biol Med.
87:491–518. 2014.PubMed/NCBI
|
|
11
|
Anguille S, Smits EL, Lion E, van Tendeloo
VF and Berneman ZN: Clinical use of dendritic cells for cancer
therapy. Lancet Oncol. 15:e257–e267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu YG, Wu GZ, Wang L, Zhang YY, Li Z and
Li DC: Tumor cell lysate-pulsed dendritic cells induce a T cell
response against colon cancer in vitro and in vivo. Med Oncol.
27:736–742. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brown CE, Starr R, Martinez C, Aguilar B,
D'Apuzzo M, Todorov I, Shih CC, Badie B, Hudecek M, Riddell SR and
Jensen MC: Recognition and killing of brain tumor stem-like
initiating cells by CD8+ cytolytic T cells. Cancer Res.
69:8886–8893. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang S, Darrow TL, Vervaert CE and Seigler
HF: Immunotherapeutic potential of tumor antigen-pulsed and
unpulsed dendritic cells generated from murine bone marrow. Cell
Immunol. 179:84–95. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vlashi E and Pajonk F: Cancer stem cells,
cancer cell plasticity and radiation therapy. Semin Cancer Biol.
31:28–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dawood S, Austin L and Cristofanilli M:
Cancer stem cells: Implications for cancer therapy. Oncology
(Williston Park). 28:1101–1107, 1110. 2014.PubMed/NCBI
|
|
17
|
Wang T, Shigdar S, Gantier MP, Hou Y, Wang
L, Li Y, Shamaileh HA, Yin W, Zhou SF, Zhao X and Duan W: Cancer
stem cell targeted therapy: Progress amid controversies.
Oncotarget. 6:44191–44206. 2015.PubMed/NCBI
|
|
18
|
Snyder V, Reed-Newman TC, Arnold L, Thomas
SM and Anant S: Cancer stem cell metabolism and potential
therapeutic targets. Front Oncol. 8:2032018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu KJ, Wang CC, Chen LT, Cheng AL, Lin
DT, Wu YC, Yu WL, Hung YM, Yang HY, Juang SH, et al: Generation of
carcinoembryonic antigen (CEA)-specific T-cell responses in
HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients
after vaccination with dendritic cells loaded with CEA peptides.
Clin Cancer Res. 10:2645–2651. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hasegawa H, Mori M, Haraguchi M, Ueo H,
Sugimachi K and Akiyoshi T: Expression spectrum of melanoma
antigen-encoding gene family members in colorectal carcinoma. Arch
Pathol Lab Med. 122:551–554. 1998.PubMed/NCBI
|
|
21
|
Park DI, Kang MS, Oh SJ, Kim HJ, Cho YK,
Sohn CI, Jeon WK, Kim BI, Han WK, Kim H, et al: HER-2/neu
overexpression is an independent prognostic factor in colorectal
cancer. Int J Colorectal Dis. 22:491–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Q, Cui XX, Liang PF, Dou JX, Liu ZY
and Sun WW: Immunotherapy with dendritic cells and cytokine-induced
killer cells for MDA-MB-231 breast cancer stem cells in nude mice.
Am J Transl Res. 8:2947–2955. 2016.PubMed/NCBI
|
|
23
|
Dashti A, Ebrahimi M, Hadjati J,
Memarnejadian A and Moazzeni SM: Dendritic cell based immunotherapy
using tumor stem cells mediates potent antitumor immune responses.
Cancer Lett. 374:175–185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jachetti E, Mazzoleni S, Grioni M,
Ricupito A, Brambillasca C, Generoso L, Calcinotto A, Freschi M,
Mondino A, Galli R and Bellone M: Prostate cancer stem cells are
targets of both innate and adaptive immunity and elicit
tumor-specific immune responses. Oncoimmunology. 2:e245202013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang XF, Weng DS, Pan K, Zhou ZQ, Pan QZ,
Zhao JJ, Tang Y, Jiang SS, Chen CL, Li YQ, et al:
Dendritic-cell-based immunotherapy evokes potent anti-tumor immune
responses in CD105+ human renal cancer stem cells. Mol Carcinog.
56:2499–2511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun JC, Pan K, Chen MS, Wang QJ, Wang H,
Ma HQ, Li YQ, Liang XT, Li JJ, Zhao JJ, et al: Dendritic
cells-mediated CTLs targeting hepatocellular carcinoma stem cells.
Cancer Biol Ther. 10:368–375. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Q, Lu L, Tao H, Xue C, Teitz-Tennenbaum
S, Owen JH, Moyer JS, Prince ME, Chang AE and Wicha MS: Generation
of a novel dendritic-cell vaccine using melanoma and squamous
cancer stem cells. J Vis Exp. e505612014.PubMed/NCBI
|
|
28
|
Gilboa E: DC-based cancer vaccines. J Clin
Invest. 117:1195–1203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fields RC, Shimizu K and Mulé JJ: Murine
dendritic cells pulsed with whole tumor lysates mediate potent
antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci
USA. 95:9482–9487. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Boczkowski D, Nair SK, Snyder D and Gilboa
E: Dendritic cells pulsed with RNA are potent antigen-presenting
cells in vitro and in vivo. J Exp Med. 184:465–472. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nestle FO, Alijagic S, Gilliet M, Sun Y,
Grabbe S, Dummer R, Burg G and Schadendorf D: Vaccination of
melanoma patients with peptide- or tumor lysate-pulsed dendritic
cells. Nat Med. 4:328–332. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ruben JM, van den Ancker W, Bontkes HJ,
Westers TM, Hooijberg E, Ossenkoppele GJ, de Gruijl TD and van de
Loosdrecht AA: Apoptotic blebs from leukemic cells as a preferred
source of tumor-associated antigen for dendritic cell-based
vaccines. Cancer Immunol Immunother. 63:335–345. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rosenberg SA: Cancer vaccines based on the
identification of genes encoding cancer regression antigens.
Immunol Today. 18:175–182. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kyte JA and Gaudernack G: Immuno-gene
therapy of cancer with tumor-mRNA transfected dendritic cells.
Cancer Immunol Immunother. 55:1432–1442. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nair SK, Boczkowski D, Morse M, Cumming
RI, Lyerly HK and Gilboa E: Induction of primary carcinoembryonic
antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human
dendritic cells transfected with RNA. Nat Biotechnol. 16:364–369.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pan K, Zhao JJ, Wang H, Li JJ, Liang XT,
Sun JC, Chen YB, Ma HQ, Liu Q and Xia JC: Comparative analysis of
cytotoxic T lymphocyte response induced by dendritic cells loaded
with hepatocellular carcinoma-derived RNA or cell lysate. Int J
Biol Sci. 6:639–648. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Song Z, Guo C, Li Y, Tan B, Fan L and Xiao
J: Enhanced antitumor effects of a dendritic cell vaccine
transfected with gastric cancer cell total RNA carrying the 4-1BBL
gene in vitro. Exp Ther Med. 3:319–323. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van Tendeloo VF, Ponsaerts P, Lardon F,
Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR and Berneman
ZN: Highly efficient gene delivery by mRNA electroporation in human
hematopoietic cells: Superiority to lipofection and passive pulsing
of mRNA and to electroporation of plasmid cDNA for tumor antigen
loading of dendritic cells. Blood. 98:49–56. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qui P, Ziegelhoffer P, Sun J and Yang NS:
Gene gun delivery of mRNA in situ results in efficient transgene
expression and genetic immunization. Gene Ther. 3:262–268.
1996.PubMed/NCBI
|
|
40
|
Lutz MB, Kukutsch N, Ogilvie AL, Rössner
S, Koch F, Romani N and Schuler G: An advanced culture method for
generating large quantities of highly pure dendritic cells from
mouse bone marrow. J Immunol Methods. 223:77–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schnurr M, Galambos P, Scholz C, Then F,
Dauer M, Endres S and Eigler A: Tumor cell lysate-pulsed human
dendritic cells induce a T-cell response against pancreatic
carcinoma cells: An in vitro model for the assessment of tumor
vaccines. Cancer Res. 61:6445–6450. 2001.PubMed/NCBI
|
|
42
|
Jin L, Hope KJ, Zhai Q, Smadja-Joffe F and
Dick JE: Targeting of CD44 eradicates human acute myeloid leukemic
stem cells. Nat Med. 12:1167–1174. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dalerba P, Dylla SJ, Park IK, Liu R, Wang
X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, et al:
Phenotypic characterization of human colorectal cancer stem cells.
Proc Natl Acad Sci USA. 104:10158–10163. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Du L, Wang H, He L, Zhang J, Ni B, Wang X,
Jin H, Cahuzac N, Mehrpour M, Lu Y and Chen Q: CD44 is of
functional importance for colorectal cancer stem cells. Clin Cancer
Res. 14:6751–6760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Janikashvili N, Larmonier N and Katsanis
E: Personalized dendritic cell-based tumor immunotherapy.
Immunotherapy. 2:57–68. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aarntzen EH, Figdor CG, Adema GJ, Punt CJ
and de Vries IJ: Dendritic cell vaccination and immune monitoring.
Cancer Immunol Immunother. 57:1559–1568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nestle FO, Farkas A and Conrad C:
Dendritic-cell-based therapeutic vaccination against cancer. Curr
Opin Immunol. 17:163–169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tuyaerts S, Aerts JL, Corthals J, Neyns B,
Heirman C, Breckpot K, Thielemans K and Bonehill A: Current
approaches in dendritic cell generation and future implications for
cancer immunotherapy. Cancer Immunol Immunother. 56:1513–1537.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kokhaei P, Choudhury A, Mahdian R, Lundin
J, Moshfegh A, Osterborg A and Mellstedt H: Apoptotic tumor cells
are superior to tumor cell lysate, and tumor cell RNA in induction
of autologous T cell response in B-CLL. Leukemia. 18:1810–1815.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Junking M, Grainok J, Thepmalee C,
Wongkham S and Yenchitsomanus PT: Enhanced cytotoxic activity of
effector T-cells against cholangiocarcinoma by dendritic cells
pulsed with pooled mRNA. Tumour Biol. 39:10104283177333672017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tyagi RK, Mangal S, Garg N and Sharma PK:
RNA-based immunotherapy of cancer: Role and therapeutic
implications of dendritic cells. Expert Rev Anticancer Ther.
9:97–114. 2009. View Article : Google Scholar : PubMed/NCBI
|
